Regulus Therapeutics
RGLS
#8838
Rank
ยฃ86.5 M
Marketcap
ยฃ1.31
Share price
-6.39%
Change (1 day)
-36.70%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -ยฃ36.01 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -ยฃ22.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 -ยฃ35.81 Million56.97%
2023 -ยฃ22.81 Million6.51%
2022 -ยฃ21.42 Million2.53%
2021 -ยฃ20.89 Million93.59%
2020 -ยฃ10.79 Million-15.41%
2019 -ยฃ12.76 Million-64.46%
2018 -ยฃ35.89 Million-33.26%
2017 -ยฃ53.77 Million-13.98%
2016 -ยฃ62.51 Million44.77%
2015 -ยฃ43.18 Million-1.63%
2014 -ยฃ43.9 Million203.6%
2013 -ยฃ14.46 Million8.65%
2012 -ยฃ13.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ3.40 B-9,611.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ6.15 B-17,290.56%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ1.47 B-4,225.54%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.08 B-22,682.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
-ยฃ0.19 Billion 409.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ76.3 Million 113.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ6.5 Billion 18,036.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ91.18 Million 154.66%๐Ÿ‡บ๐Ÿ‡ธ USA